Two posters presented at the 2024 American Society of Hematology meeting reported real-world outcomes data for patients ...

Akriti Jain, MD, discusses her presentation from the 2024 American Society of Hematology Meeting and Exposition.

The 66th American Society of Hematology (ASH) Annual Meeting & Exposition took place December 7-10, 2024, in San Diego, California; the 2025 meeting is currently scheduled to take place in Orlando ...

The Barbara Ann Karmanos Cancer Institute welcomes José Larios, M.D., transplant hematologist. Dr. Larios is a member of the ...

Dr. Sattva S. Neelapu discusses the intricacies of CAR T-cell therapy treatment and care for patients with hematologic ...

At the American Society of Hematology annual meeting, a roundtable discussion highlighted the evolving role of minimal residual disease (MRD) as a treatment endpoint in multiple myeloma, exploring its ...

Laboratory studies uncover a simple yet promising approach to enhance personalized cell therapy. A dietary supplement may ...

Hematology Oncology of Indiana Physician Research Presented at 66th ASH Annual Meeting ...

A study presented at the American Society of Hematology (ASH) annual meeting revealed that multiple myeloma patients with higher socioeconomic deprivation, as measured by the Area Deprivation Index ...

In an interview with Peers & Perspectives in Oncology, Doris M. Ponce, MD, MS, a bone marrow transplant specialist, discussed ...

A pair of assessments conducted by the American Society of Hematology (ASH) have helped identify roadblocks to improving diversity in clinical trials and elucidated the strategies ASH members use ...